Eppendorf & Science Prize for Neurobiology 2024: Call for Entries!
Eppendorf and the journal Science are now accepting applications for the 2024 Eppendorf & Science Prize for Neurobiology. This annual international research prize of US$25,000 is awarded to young scientists for their outstanding contributions to neurobiological research based on methods of molecular, cellular, systems, or organismic biology. Researchers who are not older than 35 years are invited to apply by June 15, 2024. The winner and finalists are selected by a committee of independent scientists, chaired by Science’s Senior Editor, Dr. Peter Stern.
The 2023 prize was won by the American scientist Marissa Scavuzzo, Ph.D., Case Western Reserve University School of Medicine, Cleveland, USA for her research on glial cells in the enteric nervous system in the gut.
For more about the prize and film interview with Marissa Scavuzzo, go to www.eppendorf.com/prize
About the Eppendorf Group
Eppendorf is a leading international life science company that develops, manufactures, and distributes instruments, consumables, and services for use in laboratories around the world. The product portfolio of the business units Liquid Handling, Consumables, Separation & Instrumentation and Bioprocess includes, for example, pipettes, pipette tips, centrifuges, mixers, ultra-freezers and bioreactors for cell and gene research. In addition, Eppendorf offers a wide range of high-quality consumables. In fiscal year 2022, the Eppendorf Group generated €1.23 billion in sales and invested €76 million in research and development (R&D).
Eppendorf products are used in academic and industrial research laboratories, for example in companies in the pharmaceutical, biotech, chemical and food industries. But Eppendorf products are also used in clinical or environmental analysis laboratories, in forensics and in industrial laboratories for process analysis, production, and quality assurance.
Eppendorf was founded in 1945, is headquartered in Hamburg, Germany, operates production and R&D sites in Europe, Asia and North America and has subsidiaries in 33 countries. Today, the Group employs more than 5,000 people worldwide. They all act in accordance with the purpose of the company's founders: to improve human living conditions.